170784 ⎘
Screening for compounds of potential therapeutic value Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Photo-generated carbohydrate arrays and the rapid identification of pathogen-specific antigens and antibodies
#902COMPLEXES OF TRPC DOMAINS AND SESTD1 DOMAINS AND METHODS AND USES INVOLVING THE SAME
#903Compositions and methods for identification of PARP function, inhibitors, and activators
#904METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA
#905Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists
#906LABELING OF HUMAN EPIDERMAL STEM CELLS
#907METHOD FOR INHIBITING BRASSININ OXIDASE
#908Use of specific T2R taste receptors to identify compounds that block bitter taste
#909Natriuretic peptide receptor-C agonists
#910FLUORESCENCE POLARIZATION BINDING ASSAY FOR CHARACTERIZING GLUCOKINASE LIGANDS
#911CHIMERIC HUMAN SWEET-UMAMI AND UMAMI-SWEET TASTE RECEPTORS
#912Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis C
#913COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS
#914TARGET
#915Polypeptides and methods of use
#916Methods and Compositions for Enhancing Proteasome Activity
#917METHOD OF IDENTIFYING DIAGNOSTIC REAGENTS
#918Toll-Like Receptor 9 Modulators
#919Methods and compositions for detections and modulating O-glycosylation
#920γ-Secretase substrates and methods of use
#921Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
#922Methods of predicting response of a neoplasm to an EGFR inhibitor and detecting interactions between EGFR and an EGFR regulatory protein
#923Cytoplasmic malate dehydrogenase (MDH1) targeted treatment for neurodegenerative diseases
#924Antibodies to Phosphorylated IRAK4
#925Method of screening apoptosis accelerating compound or anti-apoptotic compound and method of determining malignancy of neurodegenerative disease
#926CONSTRAINED HIV V3 LOOP PEPTIDES AS NOVEL IMMUNOGENS AND RECEPTOR ANTAGONISTS
#927AGENTS AND METHODS FOR MODULATING MACROPHAGE INHIBITORY CYTOKINE (MIC-1) ACTIVITY
#928COMPOUNDS AND METHODS FOR THE TREATMENT OF RENAL DISEASE
#929POLYNUCLEOTIDES ENCODING ACETYLCHOLINE-GATED CHLORIDE CHANNEL SUBUNITS OF CAENORHABDITIS ELEGANS
#930Cathepsin L mediated diseases and associated methods and products
#931Methods and compositions for exotoxins
#932COMPOSITIONS AND METHODS COMPRISING A LIGAND OF CHEMERINR
#933Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases
#934Method of treating inflammatory disease by inhibition of IL-17 production
#935INHIBITION OF IL-17 PRODUCTION
#936NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF
#937Modulation of platelet aggregation
#938Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
#939Core 2 GlcNAc-T inhibitors
#940Method of screening for compounds which affect the cleavage of EphA7 byγ-secretase
#941ANTIBODIES AND OTHER LIGANDS DIRECTED AGAINST KIR2DL4 RECEPTOR FOR PRODUCTION OF INTERFERON GAMMA
#942METHODS TO IDENTIFY MODULATORS OF B-RAF PROTEIN KINASE AND THEIR USE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
#943Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
#944Drug Discovery Assay for Modulators of HIF-Prolyl Hydroxylase Activity
#945Cholesterol-Regulating Complex of SIRT1 and LXR and Methods of Use
#946Enigma-Mdm2 interaction and uses thereof
#947METHOD FOR PROFILING KINASE INHIBITORS
#948PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR
#949Crystal structure of thyroid stimulating hormone receptor
#950Compositions and Methods for Treating Amyotrophic Lateral Sclerosis
#951Monomeric and dimeric fluorescent protein variants and methods for making same
#952Enzymatic methods and enzymes
#953Antibiotic peptides
#954Assays for S100 inhibitors
#955Inhibitors of PDE4 and Methods of Use
#956PDZ DOMAIN INTERACTIONS AND LIPID RAFTS
#957Assays utilizing nicotinic acetylcholine receptor subunits
#958Modulation of activity of proneurotrophins
#959METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION
#960MULTIPLE MECHANISMS FOR MODULATION OF JAK/STAT ACTIVITY
#961Cinnamoyl inhibitors of transglutaminase
#962SIVA ubiquitination and/or degradation-related activity and modulators thereof
#963Interaction of BIM with TRIM2
#964METHOD AND COMPOSITION FOR TREATING IMMUNE COMPLEX ASSOCIATED DISORDERS
#965Methods and compositions related to the structure and function of APOBEC3G
#966Method of Screening Compounds Having Anti-Amyloid Properties
#967IDENTIFICATION AND CHARACTERIZATION OF RACEMASES, DEFINITION OF PROTEIN SIGNATURES, AND A TEST FOR DETECTING D-AMINO ACID AND FOR SCREENING MOLECULES CAPABLE OF INHIBITING THE ACTIVITY OF RACEMASE, ESPECIALLY PROLINE RACEMASE
#968IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer
#969Methods for Diagnosis and Treatment of Endometrial Cancer
#970Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin and antibodies
#971Methods and products for neutralizing the harmful effects of combustion products
#972COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY
#973SCREENING METHOD UTILIZING NOVEL SUBSTRATE C-RET FOR GAMMA-SECRETASE
#974INHIBITION OF CELL PROLIFERATION
#975Malt1 specific cleavage in assay and screening method
#976Arrays of biological membranes and methods and use thereof
#977Methods for selective targeting
#978Methods of identifying agents that modulate methylation of VEGFR1 by SMYD3
#979SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING THE CDCA8-AURKB COMPLEX
#980Chimeric DRG11-responsive (DRAGON) polypetides
#981Monocot seed product comprising a human serum albumin protein
#982CONFORMATION AND ACTIVITY OF GBETA5 COMPLEXES
#983Compounds and methods for the diagnosis and treatment of amyloid associated diseases
#984Phosphorylation and regulation of AKT/PKB by the rictor-mTOR complex
#985Compositions and methods for improving bone mass through modulation of receptors of PTH and fragments thereof
#986Detection Assays and Use Thereof
#987KLOTHO BETA
#988METHODS OF IDENTIFYING ACTIVATORS OF LYN KINASE
#989Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
#990C-terminal domain truncation of mGluR1α by calpain and uses thereof
#991NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB
#992DETECTION OF INFLUENZA VIRUS
#993UL97 INHIBITORS FOR TREATMENT OF PROLIFERATIVE DISORDERS
#994Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
#995METHODS OF DIAGNOSIS OF SPINAL MUSCULAR ATROPHY AND TREATMENTS THEREOF
#996High-throughput assay for evaluating dipeptidyl peptidase I activity
#997Disheveled PDZ modulators
#998Compound containing farnesyl diphosphate for modulating TRPV3 function and use thereof
#999Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
#1000Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
#1001Biglycan and related therapeutics and methods of use
#1002METHOD FOR DETECTING THE BINDING BETWEEN MDM2 AND THE PROTEASOME
#1003Regulation of cell survival by HSP90 and IP6K2
#1004Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
#1005Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
#1006Nicotinic desensitizers and methods of selecting, testing, and using them
#1007METHODS AND COMPOSITIONS FOR TREATING CERVICAL CANCER
#1008Method using a nonlinear optical technique for detection of interactions involving a conformational change
#1009Mutagenesis of aspergillus fungi and genes essential for growth
#1010Fluorescent neutralization and adherence inhibition assays
#1011EXPRESSION OF HUMAN MILK PROTEINS IN TRANSGENIC PLANTS
#1012METHOD FOR PREVENTION OF TUMOR
#1013Protein-Protein Interaction Biosensors and Methods of Use Thereof
#1014Novel Assay for Inositol Phosphorylceramide Synthase Activity
#1015METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF INFLUENZA
#1016Optical molecular sensors for cytochrome P450 activity
#1017SIR2 Activity
#1018Botulinum neurotoxin E receptors and uses thereof
#1019Cell death inhibitor
#1020Method for designing a drug regime for HIV-infected patients
#1021MUC1 and galectin-3
#1022Means and methods for the production of amyloid oligomers
#1023METHODS FOR SCREENING FOR MODULATORS OF CCRL2
#1024DETECTION OF INFLUENZA VIRUS
#1025PROTEIN KINASE C IOTA
#1026Compositions and methods for treatment of eye disorders
#1027COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS
#1028PANCREATIC CANCER BIOMARKERS
#1029METHOD FOR IMPROVING THE PHARMACOKINETICS OF DRUGS METABOLIZED BY UGT2B10
#1030Allergen-binding IgE monoclonal antibodies and method for preparing hypoallergens
#1031Tri-demethylation-capable protein complex, method of its preparation and its use
#1032High-content and high throughput assays for identification of lipid-regulating pathways, and novel therapeutic agents for lipid disorders
#1033Heparin Compositions and Selectin Inhibition
#1034WSTF REGULATES THE DNA DAMAGE RESPONSE OF H2A.X VIA NOVEL TYROSINE KINASE ACTIVITY
#1035PROTECTIVE EFFECTS OF INHIBITING THE INTERACTION OF CALMODULIN AND MUTANT HUNTINGTIN PROTEIN
#1036Identification of therapeutic agents for HIV infection
#1037Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
#1038Methods for the identification of PI3K interacting molecules and for the purification of PI3K
#1039Methods and reagents for the analysis and purification of polysaccharides
#1040Sumoylation Control Agent and Uses Thereof
#1041IL-1 ZETA, IL-1 ZETA SPLICE VARIANTS AND XREC2 DNAS AND POLYPEPTIDES
#1042Compositions and methods for treating diseases associated with T-box and N-Myc
#1043MODULATORS OF NEURONAL REGENERATION
#1044METHODS AND AGENTS FOR TREATING TUBERCULOSIS
#1045Amelioration of Inflammatory Arthritis By Targeting the Pre-ligand Assembly Domain (Plad) of Tumor Necrosis Factor Receptors
#1046METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#1047Human Tumor Necrosis Factor TR21 and Methods Based Thereon
#1048T cell proteins and nucleotides encoding the same
#1049COMPOSITIONS FOR MANIPULATING THE LIFESPAN AND STRESS RESPONSE OF CELLS AND ORGANISMS
#1050Compositions and methods for treating inflammatory conditions of the bowel
#1051Method for screening anti-HIV Drugs and a diagnostic method of AIDS
#1052Human Blood Proteins Expressed in Monocot Seeds
#1053Systematic identification of new anti-prion drugs by high-throughput screening based on scanning for intensely fluorescent targets (sift)
#1054Anti-HIMF antibodies to treat lung diseases
#1055Compositions and Methods to Treat Bone Related Disorders
#1056RECEPTOR FOR AMYLOID BETA AND USES THEREOF
#1057Methods and composition of treating a flaviviridae family viral infection
#1058Modulation of Glutamine Synthetase Activity
#1059Fluorescent Analogs Of The Islet Amyloid Polypeptide
#1060Methods and compositions of treating a family viral infection
#1061Nucleic acids encoding a heme binding protein polypeptide
#1062Methods of identifying modulators of ChemerinR polypeptides
#1063Use of TGF-Beta Antagonists in Treatment of Parathyroid-Related Disorders
#1064High Throughput Screening Method of Binding Inhibitor Between caspase3 and XIAP and Binding Inhibitor Screened Thereby
#1065Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
#1066SRA binding protein
#1067METHODS TO TREAT OR PREVENT HORMONE-RESISTANT PROSTATE CANCER USING siRNA SPECIFIC FOR PROTOCADHERIN-PC, OR OTHER INHIBITORS OF PROTOCADHERIN-PC EXPRESSION OR ACTIVITY
#1068Methods for the Screening of Antibacterial Substances
#1069Methods for Identifying FZD8 Modulators and the Use of such Modulators for Treating Osteoarthritis
#1070Methods for predicting psychotropic drugs which elicit weight gain
#1071Method for treating ocular cancer
#1072Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#1073METHOD FOR IDENTIFYING BPLP AND OPIORPHIN AGONISTS OR ANTAGONISTS
#1074Polypeptides that bind APRIL
#1075NON-SMALL CELL LUNG CANCER-RELATED GENE, ANLN, AND ITS INTERACTION WITH RhoA
#1076METHODS FOR TREATING PATHOLOGICAL NEOVASCULARIZATION
#1077Methods of inhibiting the PSGL-1-mediated adhesion and chemokine-mediated migration with PSGL-1-specific antibodies
#1078Compositions and methods for the modulation of PGRMC1
#1079Cell Model for Alzheimer's Disease Pathology
#1080Compositions And Methods For Identifying Modulars Of TRPV2
#1081USP47 inhibtors and methods to induce apoptosis
#1082Regulation of Microphage Migration Inhibitory Factor (MIF) Activity
#1083Method of treatment using an anti-IL-B50 antibody
#1084Purified TNFR preparations
#1085Identification of substances that inhibit NEMO oligomerization
#1086E3-INDEPENDENT UBIQUITINYLATION ASSAY
#1087Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
#1088Natural ligand of G protein coupled receptor RCC356 and uses thereof
#1089Polypeptides having a functional domain of interest and methods of identifying and using same
#1090Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
#1091Poly(A) polymerase
#1092APOBEC3 mediated DNA editing
#1093HUMAN BLOOD PROTEINS EXPRESSED IN MONOCOT SEEDS
#1094INHIBITION OF GLIOTOXIN
#1095Mutant IGFBP-3 molecules that do not bind to IGFs, but retain their ability to functionally bind IGFBP-3 receptor
#1096Method of identifying compounds useful to treat neuronal degenerative diseases
#1097Use Of A Growth-Stimulating Protein
#1098Cancer biomarker genes and gene products and methods for using the same
#1099Screening For Anti-Cancer Compounds Using Netrin-1 Activity
#1100Metadherin polypeptides, encoding nucleic acids and methods of use
#1101LGI, LINGO and p75NTR family members: novel modulators of neuronal growth
#1102THERAPEUTIC AGENTS FOR ALZHEIMER'S DISEASE AND CANCER
#1103IFN-λ polypeptides and compositions
#1104INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE
#1105Anti-zB7H6 antibody-drug conjugates
#1106Methods and compositions for the diagnosis and treatment of schizophrenia
#1107NK1-BASED POLYPEPTIDES AND RELATED METHODS
#1108Screening and therapeutic method for NSCLC targeting CDCA1-KNTC2 complex
#1109METHODS FOR IDENTIFICATION OF INHIBITORS OF ENZYME ACTIVITY
#1110LITAF binding site peptides and methods of using the same
#1111Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
#1112Anti-bacterial drug targeting of genome maintenance interfaces
#1113F1F0-ATPASE INHIBITORS AND RELATED METHODS
#1114Specific binding sites in collagen for integrins and use thereof
#1115Neuregulin variants and methods of screening and using thereof
#1116Nuclear receptor assay
#1117NEGATIVE REGULATION OF HYPOXIA INDUCIBLE FACTOR 1 BY OS-9
#1118METHODS FOR TESTING ANTI-THROMBOTIC AGENTS
#1119Method of identifying a potential substrates of an O-methyltransferase
#1120IAP BIR domain binding compounds
#1121Compositions and method of treating hypoxia-associated diseases
#1122METHOD OF SCREENING USING c-MET, A NOVEL SUBSTRATE FOR GAMMA-SECRETASE
#1123Auto-antibodies against the melanocortin-4 receptor
#1124Methods of modulating SMYD3 for treatment of cancer
#1125sVEGFR-2 and its role in lymphangiogenesis modulation
#1126Insecticidal compounds and methods for selection thereof
#1127COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF HUMAN HERPESVIRUS (HHV)-6
#1128USE OF A GLP-1 MOLECULE FOR TREATMENT OF BILIARY DYSKINESIA AND/OR BILIARY PAIN/DISCOMFORT
#1129Methods and compositions for treating cellular proliferative diseases
#1130Tomoregulin-2-antibody compositions and methods for the diagnosis and treatment of Alzheimer's disease
#1131T Cell Adhesion Molecule and Antibody Thereto
#1132ASSAY FOR IDENTIFYING INHIBITORS OF NEURONAL APOPTOTIC PATHWAYS
#1133METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE PHB DOMAIN PROTEIN ACTIVITY AND COMPOSITIONS THEREOF
#1134Method for determining inhibitors of neurotrypsin
#1135Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
#1136Screening compounds for activity in modulating chloride ion transport
#1137Neutrokine-alpha antibodies and methods of use thereof
#1138Methods for inhibiting VEGF-D
#1139Modulators of neuronal regeneration
#1140METHODS AND COMPOSITIONS FOR ANTAGONIZING ANTI-APOPTOTIC Bcl-2-FAMILY PROTEINS
#1141Orthogonal chemical inducer of dimerization
#1142Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#1143BIOSIGNAL MEASURING APPARATUS
#1144Modulating robo: ligand interactions
#1145Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell
#1146Modified defensins and their use
#1147JAB1 as a prognostic marker and a therapeutic target for human cancer
#1148UNIVERSAL FLUORESCENT SENSORS
#1149Methods for characterizing enzyme inhibitors
#1150Methods for identifying modulators of P2RY14
#1151Methods for diagnosis and treatment of epithelial-derived cancers
#1152Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1
#1153Method of screening for compounds which affect the processing of EphA4 by γ-secretase
#1154Method for modulating insulin production
#1155Mitochondrial localization of MUC1
#1156Inhibition of polo kinase by matrimony maintains G2 arrest in the meiotic cell cycle
#1157Inhibitors Of Biotin Protein Ligase
#1158METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS
#1159PAR-4 RELATED METHODS AND COMPOSITIONS
#1160Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors
#1161Bivalent thrombin binding molecules comprising linkers
#1162NOVEL UBIQUITIN LIGASES AS THERAPEUTIC TARGETS
#1163β-galactosidase donor fragments
#1164Asbestos detection method, asbestos detection agent, asbestos detection kit, method for screening candidate for agent aiming at preventing or treating disease for which asbestos is causative or worsening factor
#1165Pharmaceutical compositions for treating diseases associated with NF-κB activity
#1166Methods and compositions relating to promoter regulation by MUC1 and KLF proteins
#1167Methods for selective targeting
#1168Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3
#1169Suppression of sPLA2-integrin binding for treating an inflammatory condition
#1170Cell-based assays for G-protein-coupled receptor-mediated activities
#1171Human T2R receptors for ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators
#1172Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins
#1173COMPOSITIONS AND METHODS FOR TREATING DISEASES
#1174ActRIIB Fusion Polypeptides and Uses Therefor
#1175METHODS OF TREATING BONE DISORDERS WITH MODULATORS OF AXL
#1176ActRIIB Fusion Polypeptides and Uses Therefor
#1177COMPOSITIONS AND METHODS FOR TREATING DISEASES
#1178Nucleic acids encoding ChemerinR ligands
#1179Modified heparinase III and methods of sequencing therewith
#1180Compounds and Methods for Treating Obesity
#1181SCREENING FOR MODULATORS OF METALATION PATHWAYS FOR METALLOPROTEINS
#1182METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION
#1183Compositions and methods for treatment of colorectal cancer
#1184USE OF LLT1 AND/OR CD161 FOR MODULATTING THE ACTIVITY OF CELLS OF THE IMMUNE SYSTEM
#1185CHEMICAL INHIBITORS OF BFL-1 AND RELATED METHODS
#1186Methods of treatment using antibodies to neutrokine-alpha
#1187MAP3Ks as modifiers of the p53 pathway and methods of use
#1188ENZYME REGULATING ETHER LIPID SIGNALING PATHWAYS
#1189NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB
#1190Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation
#1191Ligand for G-protein coupled receptor FPRL2
#1192Optical Disc Apparatus
#1193Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)
#1194Compositions comprising a ligand of Chemerin R
#1195Method for Identifying Modulators of Keah6 Useful for Treating Alzheimer's Disease
#1196Tyrosylprotein sulfotransferases and methods of use thereof
#1197DBC1, a novel native inhibitor of anti-aging protein SIRT1
#1198Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
#1199Methods for identifying agents for treating cardiovascular disease using inhibition of myeloperoxidase binding
#1200Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators